Karolinska Development exits Pharmanest
Karolinska Development AB has sold its stake in Pharmanest AB to a consortium comprised of The Foundation for Baltic and East European Studies, Recipharm Venture Fund AB and Praktikerinvest AB. Sweden-based Pharmanest AB is a developer of products for local pain relief in obstetrics and gynecology.
9 July 2015•2 mins read
